The Hemagglutinin A Stem Antibody MEDI8852 Prevents and Controls Disease and Limits Transmission of Pandemic Influenza Viruses

BACKGROUND: MEDI8852 is a novel monoclonal antibody (mAb) that neutralizes both group I and group II influenza A viruses (IAVs) in vitro. We evaluated whether MEDI8852 was effective for prophylaxis and therapy against representative group I (H5N1) and group II (H7N9) pandemic IAVs in mice and ferret...

Descripción completa

Detalles Bibliográficos
Autores principales: Paules, Catharine I, Lakdawala, Seema, McAuliffe, Josephine M, Paskel, Myeisha, Vogel, Leatrice, Kallewaard, Nicole L, Zhu, Qing, Subbarao, Kanta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Major Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5853468/
https://www.ncbi.nlm.nih.gov/pubmed/28633457
http://dx.doi.org/10.1093/infdis/jix292

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5853468/
https://www.ncbi.nlm.nih.gov/pubmed/28633457
http://dx.doi.org/10.1093/infdis/jix292

Ejemplares similares